People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids to quell their pain, according to a major update of treatment guidelines.
For the estimated one-third of people with focal epilepsy who don’t respond well to initial medications, new research offers significant reason for optimism.
